Activation of CXCR4 signaling increases the migration and invasion of NSCLC cells and blockade of this signaling reverses the effect in vitro and suppresses metastatic activity of these cells in vivo using neutralizing antibody10. This evidence concerns the gene CXCR4 and non-small cell lung carcinoma.